Mary Tagliaferri
Chief Tech/Sci/R&D Officer presso NEKTAR THERAPEUTICS
Patrimonio netto: 472 498 $ in data 31/03/2024
Profilo
Mary A.
Tagliaferri was the founder of Bionovo, Inc. (founded in 2002) where she held the title of President, Secretary, Treasurer & Director from 2011 to 2012.
She currently holds the position of Independent Director at Enzo Biochem, Inc. (since 2020), Y-mAbs Therapeutics, Inc. (since 2024), and Nektar Therapeutics (since 2015), where she serves as Chief Medical Officer & Senior Vice President.
In her former roles, Dr. Tagliaferri served as a Director at Atossa Therapeutics, Inc. She was also an Independent Director at Rayzebio, Inc. from 2021 to 2024.
Additionally, she held the position of Secretary, Treasurer & Chief Regulatory Officer at Lighten Up Enterprises International, Inc. Furthermore, she served as Chief Medical Officer at Kanglaite USA, Inc. from 2012 to 2014.
Dr. Tagliaferri obtained her undergraduate degree from Cornell University in 1988.
She earned her doctorate degree from The University of California, San Francisco in 2002.
She also holds a graduate degree from the American College of Traditional Chinese Medicine, conferred in 1995.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ENZO BIOCHEM, INC.
0.61% | 31/01/2024 | 312 383 ( 0.61% ) | 396 726 $ | 31/03/2024 |
| 12/03/2024 | 4 660 ( 0.01% ) | 75 772 $ | 31/03/2024 |
Posizioni attive di Mary Tagliaferri
| Società | Posizione | Inizio |
|---|---|---|
| NEKTAR THERAPEUTICS | Chief Tech/Sci/R&D Officer | 17/04/2023 |
| ENZO BIOCHEM, INC. | Director/Board Member | 17/11/2020 |
| Y-MABS THERAPEUTICS, INC. | Director/Board Member | 29/02/2024 |
Precedenti posizioni note di Mary Tagliaferri
| Società | Posizione | Fine |
|---|---|---|
| RAYZEBIO, INC. | Director/Board Member | 26/02/2024 |
| Kanglaite USA, Inc. | Chief Tech/Sci/R&D Officer | 01/06/2014 |
| BIONOVO INC. | Founder | 01/06/2012 |
| Lighten Up Enterprises International, Inc. | Chief Tech/Sci/R&D Officer | 05/07/2005 |
| ATOSSA THERAPEUTICS, INC. | Director/Board Member | - |
Formazione di Mary Tagliaferri
| Cornell University | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
| American College of Traditional Chinese Medicine | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| ENZO BIOCHEM, INC. | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| Y-MABS THERAPEUTICS, INC. | Health Technology |
| RAYZEBIO, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
| Lighten Up Enterprises International, Inc. | Finance |
Bionovo, Inc.
 Bionovo, Inc. Pharmaceuticals: MajorHealth Technology Bionovo, Inc. is a clinical drug discovery and development company, which is focused on developing drugs for the treatment of unmet medical needs in women's health and cancer. The company was founded by Isaac Cohen and Mary Tagliaferri in February 2002 and is headquartered in Emeryville, CA. | Health Technology |
| Kanglaite USA, Inc. |
- Borsa valori
- Insiders
- Mary Tagliaferri
